HEM Pharma Inc
KOSDAQ:376270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
C
|
Compagnie de Saint Gobain SA
F:GOB
|
FR |
|
Promotora de Informaciones SA
MAD:PRS
|
ES |
|
Anadolu Efes Biracilik ve Malt Sanayii AS
F:EF41
|
TR |
|
S
|
Southern Co
F:SOT
|
US |
|
F
|
Fresenius SE & Co KGaA
XMUN:FRE
|
DE |
|
Menicon Co Ltd
F:5FR
|
JP |
|
J
|
J.M. Smucker Co
XMUN:JM2
|
US |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
Metal Powder Works Ltd
F:3OV
|
AU |
|
Precious Shipping PCL
OTC:PSGFF
|
TH |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for HEM Pharma Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What HEM Pharma Does
HEM Pharma, Inc. engages in the provision of microbiome solutions. The company is headquartered in Suwon, Gyeonggi-Do and currently employs 101 full-time employees. The company went IPO on 2024-11-05. The firm mainly operates two businesses. The customized healthcare services business mainly researching and discovery the relationship between diseases and human body’s various microbiota and beneficial substances produced by microorganisms to provide the optimal solution for individuals.
- Headquarters
- Korea KR
- Employees
- 63
- IPO date
- Nov 5, 2024
